𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The clinical impression of severity index for Parkinson's disease: International validation study

✍ Scribed by Pablo Martínez-Martín; Carmen Rodríguez-Blázquez; Maria João Forjaz; Jesús de Pedro


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
92 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This study sought to provide further information about the psychometric properties of the Clinical Impression of Severity Index for Parkinson's Disease (CISI‐PD), in a large, international, cross‐culturally diverse sample. Six hundred and fourteen patients with PD participated in the study. Apart from the CISI‐PD, assessments were based on Hoehn & Yahr (HY) staging, the Scales for Outcomes in PD‐Motor (SCOPA‐M), ‐Cognition (SCOPA‐COG) and ‐Psychosocial (SCOPA‐PS), the Cumulative Illness Rating Scale‐Geriatrics, and the Hospital Anxiety and Depression Scale. The total CISI‐PD score displayed no floor or ceiling effects. Internal consistency was 0.81, the test–retest intraclass correlation coefficient was 0.84, and item homogeneity was 0.52. Exploratory and confirmatory factor analysis (CFI = 0.99, RMSEA = 0.07) confirmed CISI‐PD's unifactorial structure. The CISI‐PD showed adequate convergent validity with SCOPA‐COG and SCOPA‐M (r~S~ = 0.46–0.85, respectively) and discriminative validity for HY stages and disease duration (P < 0.0001). In a multiple regression model, main CISI‐PD predictors were SCOPA‐M, disease duration, and depression. The results obtained were not only comparable to but also extended those yielded by the preliminary validation study, thus showing that the CISI‐PD is a valid instrument to measure clinical impression of severity in PD. Its simplicity and easy application make it an attractive and useful tool for clinical practice and research. © 2008 Movement Disorder Society


📜 SIMILAR VOLUMES


Global versus factor-related impression
✍ Pablo Martínez-Martín; M. João Forjaz; Esther Cubo; Belén Frades; Jesús de Pedro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract In Parkinson's disease (PD), the Clinical Global Impression of Severity (CGIS) is often used as an additional outcome in clinical trials. It is hypothesized that this measure summarizes clinical assessment and is mainly influenced by the rating of four domains, namely, motor signs, disa

Familial aggregation of Parkinson's dise
✍ Walter A. Rocca; Shannon K. McDonnell; Kari J. Strain; James H. Bower; J. Eric A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

## Abstract Data on the familial aggregation of Parkinson's disease (PD) remain conflicting. We conducted a historical cohort study of 1,001 first‐degree relatives of 162 probands with PD and of 851 relatives of 147 control probands representative of the population of Olmsted County, Minnesota (fro

Validation of the questionnaire for impu
✍ Daniel Weintraub; Staci Hoops; Judy A. Shea; Kelly E. Lyons; Rajesh Pahwa; Erika 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

## Abstract As no comprehensive assessment instrument for impulse control disorders (ICDs) in Parkinson's disease (PD) exists, the aim of this study was to design and assess the psychometric properties of a self‐administered screening questionnaire for ICDs and other compulsive behaviors in PD. The

Magnetic resonance imaging for evaluatio
✍ Jordi Rimola; Ingrid Ordás; Sonia Rodriguez; Orlando García-Bosch; Montserrat Ac 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 1 views

Background: The use of magnetic resonance imaging (MRI) for assessment of Crohn's disease (CD) is expanding. The aim of this study is to define and provide an external validation of the MRI predictors of active CD, severe CD, and a quantitative Magnetic Resonance Index of Activity (MaRIA). Methods:

The Unified Parkinson's Disease Rating S
✍ Sergio E. Starkstein; Marcelo Merello 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

## Abstract The objective of this study was to examine the validity of the mentation, behavior, and mood items included in Part I of the Unified Parkinson's Disease Rating Scale (UPDRS) and to assess its usefulness to screen for dementia, psychosis, depression, and apathy. A consecutive series of 1